A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib

Clinical trial NCT00689507 · COMPLETED

Trial details

NCT number: NCT00689507
Sponsor: Applied Molecular Evolution
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2008-03-01
Primary completion: 2013-01-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.